Page 467 - TBE_Book_V2_2019
P. 467
Chapter 14: Prevention
64. Stefanoff P, Polkowska A, Giambi C, et al. 73. WHO. Vaccines against tick-borne encephalitis
Reliable surveillance of tick-borne (TBE): WHO position paper, 10 June, 2011
encephalitis in European countries is [Grading crossprotection]. 2011; available at:
necessary to improve the quality of vaccine http://www.who.int/immunization/
recommendations. Vaccine. 2011;29:1283- TBE_grad_crossprotection.pdf?ua=1.
8.
74. Kluger G, Schöttler A, Waldvogel K, et al.
65. Andersson CR, Vene S, Insulander M, Tickborne encephalitis despite specific
Lindquist L, Lundkvist A, Gunther G. Vaccine immunoglobulin prophylaxis. Lancet.
failures after active immunization against 1995;346:1502.
tick-borne encephalitis. Vaccine.
2010;28:2827-31. 75. Kreil TR, Maier E, Fraiss S, Eibl MM.
Neutralizing antibodies protect against
66. Koppi S, Faé P, Hartmann G, Höftberger R, lethal flavivirus challenge but allow for the
Holzmann H. [Fatal outcome of tick-borne development of active humoral immunity to
encephalitis despite complete active a nonstructural virus protein. J Virol.
vaccination]. Nervenarzt. 2011;82:506, 8. 1998;72:3076-81.
67. Plisek S, Honegr K, Beran J. TBE infection in an 76. Brӧker M, Kollaritsch H. After a tick bite in a
incomplete immunized person at-risk who lives tick-borne encephalitis virus endemic area:
in a high-endemic area—impact on current current positions about post-exposure
recommendations for immunization of high- treatment. Vaccine. 2008;26:863-8.
risk groups. Vaccine. 2008;26:301-4.
77. Pen’evskaia N, Rudakov N. [Efficiency of use of
68. Stiasny K, Holzmann H, Heinz FX. immunoglobulin preparations for the
Characteristics of antibody responses in postexposure prevention of tick-borne
tick-borne encephalitis vaccination encephalitis in Russia (a review of semi-
breakthroughs. Vaccine. 2009;27:7021-6. centennial experience)]. Med Parazitol (Mosk).
2010;1:53-9.
69. Kollaritsch H, Paulke-Korinek M,
Holzmann H, Hombach J, Bjorvatn B, 78. Rabel PO, Planitzer CB, Farcet MR,
Barrett A. Vaccines and vaccination Kreil TR. Tick-borne encephalitis virus-
against tick-borne encephalitis. Exp Rev neutralizing antibodies in different
Vaccines. 2012;11:1103-19. immunoglobulin preparations. Clin
Vaccine Immunol. 2012;19:623-5.
70. Weinzettel R, Ertl S, Zwiauer K. [FSME
monitoring: monitoring of adverse events of 79. BMGF. Impfplan Österreich 2017.
tick-borne-encephalitis vaccines by selected Vienna, Austria: Ministerium
paediatricians and general practitioners]. Frauen Gesundheit;2017.
Wien Med Wochenschr. 2007;157:107-10.
80. Baumhackl U, Franta C, Retzl J, Salomonowitz
71. WHO. Vaccines against tick-borne encephalitis
E, Eder G. A controlled trial of tick-borne
(TBE): WHO position paper, 10 June, 2011 encephalitis vaccination in patients with
[Grading safety]. 2011; available at: http://
multiple sclerosis. Vaccine. 2003;21 Suppl
www.who.int/immunization/
1:S56- 61.
TBE_grad_safety.pdf? ua=1.
81. Hertzell KB, Pauksens K, Rombo L, Knight
72. Il’chenko TE, Bilalova GP, Stavitskaya NX, A, Vene S, Askling HH. Tick-borne
Solanik RG, Bistritskaya LD, Krasnilikov IV. encephalitis (TBE) vaccine to medically
Organziation of Public Health. Siberian J Med. immunosuppressed patients with
2009;2:50-5. rheumatoid arthritis: A prospective, open
-label, multi-centre study. Vaccine.
2016;34:650-5.
462
469
